Filtered Products

The pull-down assay is an effective in vitro technique for validating protein-protein interactions, commonly used to confirm interacting proteins identified by yeast two-hybrid systems or other screening methods. The fundamental principle involves immobilizing a target protein (the “bait”) onto a solid matrix. When cell lysates or other protein-containing solutions are passed through the column, proteins that interact with the bait protein bind to the matrix, while non-interacting contaminants flow through. The bound interacting proteins can then be eluted using specific buffers or conditions. Subsequent analysis typically involves SDS-PAGE separation followed by Western blotting (to detect interactions between the bait and known proteins) or mass spectrometry (to identify novel interacting partners). This method is straightforward, easy to perform, and does not require hazardous radioactive materials, making it widely applicable in protein interaction analysis.

Co-IP is a classical in vivo protein-protein interaction technology developed based on the principle of Immunoprecipitation (IP). IP is a classical protein separation technique that leverages the specific recognition and binding of antibodies to target antigens, followed by isolation and purification of the antibody-antigen complex from complex biological samples using solid-phase carriers such as Protein A/G. The core of IP lies in “fishing out a single target protein”. It is widely applied in target protein enrichment, purity verification, post-translational modification analysis, and protein expression level detection, serving as a foundational tool in proteomics research. Co-IP is a powerful protein-protein interaction validation technology built upon the foundation of classical IP. While IP focuses on isolating a single target protein, Co-IP extends this principle to “fish out the target protein along with its interacting partners”. The workflow begins with the lysis of cells or tissues under non-denaturing conditions, carefully preserving endogenous protein-protein interaction complexes in their native state. The resulting lysate is then incubated with a target-specific antibody directed against the bait protein, enabling the co-capture of both the bait and its specifically associated interacting partners (prey proteins). Following stringent washes to eliminate non-specifically bound contaminants, the co-precipitated protein complexes are eluted under denaturing conditions. The eluate is subsequently analyzed by Western blot for validation of known interactors, or by LC-MS/MS for unbiased identification of novel interacting proteins. This approach enables indirect yet highly specific detection of proteins that associate with the target protein in its native cellular context, providing robust evidence for physiological protein-protein interactions.

Yeast Two-Hybrid (Y2H) is an in vivo protein-protein interaction screening technology based on the modular structure of transcription factors. The system splits the GAL4 transcription factor into a DNA-Binding Domain (BD) and a Transcription Activation Domain (AD), which are fused to a Bait protein and a Prey protein, respectively; when the Bait and Prey physically interact within the yeast nucleus, the BD and AD are brought into proximity and reconstitute a functional transcription factor, activating downstream reporter genes (e.g., HIS3, ADE2, LacZ). Protein interaction is thus determined through auxotrophic complementation or colorimetric assays. This technique requires no protein purification and enables high-throughput screening of unknown interaction partners at the whole-genome cDNA library scale, serving as a classical tool for discovering novel protein-protein interactions.

Luciferase Complementation Assay (LCA) is a highly sensitive, high-throughput protein-protein interaction detection technology based on the principle of protein fragment complementation. The technique splits firefly luciferase (Fluc) or Renilla luciferase (Rluc) at specific sites (e.g., Gly437/Arg398) into an N-terminal fragment (N-Luc, ~1-437 aa) and a C-terminal fragment (C-Luc, ~438-550 aa); neither fragment alone possesses catalytic activity. When each fragment is fused to a target protein of interest (Bait and Prey, respectively), specific interaction between Bait and Prey within living cells brings the two luciferase fragments into close proximity, allowing them to reconstitute into a fully functional luciferase enzyme. In the presence of substrate (luciferin/coelenterazine), the reconstituted enzyme catalyzes the production of quantifiable bioluminescence signals. Signal intensity positively correlates with the affinity and binding efficiency of the protein interaction, enabling real-time, quantitative, and reversible detection of protein-protein interactions at the cellular level. LCA offers exceptionally low background, high signal-to-noise ratio, no requirement for exogenous substrate addition, compatibility with diverse cell types, and adaptability to high-throughput screening platforms. It is widely applied in drug target screening, signaling pathway dissection, membrane protein interaction studies, and detection of weak/transient interactions.

Bimolecular Fluorescence Complementation (BiFC) is an imaging technique for visualizing protein-protein interactions in living cells. The principle involves splitting a fluorescent protein (e.g., YFP, Venus, GFP) into N-terminal and C-terminal non-fluorescent fragments, each fused to a candidate interacting protein (Bait and Prey). When Bait and Prey physically interact within the cell, the two fluorescent fragments are brought into close proximity and refold to reconstitute the intact fluorescent protein structure, generating a detectable fluorescent signal. This signal appears exclusively at the subcellular location where the interaction occurs, enabling simultaneous qualitative detection and spatial localization of the interaction. However, due to its irreversibility, BiFC is not suitable for studying dynamic interactions.

Fluorescence Resonance Energy Transfer (FRET) is a physical process based on non-radiative dipole-dipole coupling between a donor fluorophore and an acceptor fluorophore. When the donor and acceptor are separated by 1-10 nm with appropriate dipole orientation, energy absorbed by the donor upon excitation is transferred non-radiatively to the acceptor, resulting in donor fluorescence quenching and enhanced acceptor emission. FRET efficiency is inversely proportional to the sixth power of the donor-acceptor distance, rendering it exquisitely sensitive to intermolecular separation. This makes FRET an indispensable technique for investigating protein-protein interactions, conformational dynamics, and real-time molecular processes in living cells.